Trademark: 87113222
Status Date
Monday, February 24, 2020
Filing Date
Friday, July 22, 2016
Published for Opposition
Tuesday, November 29, 2016
Abandoned Date
Monday, February 24, 2020
5 Human pharmaceutical preparations for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases; vaccines
Feb 24, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 24, 2020
Abandonment - No Use Statement Filed
Jul 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 5, 2019
Extension 5 Granted
Jul 2, 2019
Extension 5 Filed
Jul 2, 2019
Teas Extension Received
Jan 24, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 22, 2019
Extension 4 Granted
Jan 22, 2019
Extension 4 Filed
Jan 22, 2019
Teas Extension Received
Jun 14, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 12, 2018
Extension 3 Granted
Jun 12, 2018
Extension 3 Filed
Jun 12, 2018
Teas Extension Received
Dec 16, 2017
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2017
Extension 2 Granted
Dec 14, 2017
Extension 2 Filed
Dec 14, 2017
Teas Extension Received
Jul 25, 2017
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2017
Extension 1 Granted
Jul 13, 2017
Extension 1 Filed
Jul 24, 2017
Case Assigned To Intent To Use Paralegal
Jul 13, 2017
Teas Extension Received
Jan 24, 2017
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2016
Official Gazette Publication Confirmation E-Mailed
Nov 29, 2016
Published For Opposition
Nov 9, 2016
Notification Of Notice Of Publication E-Mailed
Oct 20, 2016
Approved For Pub - Principal Register
Oct 13, 2016
Assigned To Examiner
Jul 28, 2016
New Application Office Supplied Data Entered In Tram
Jul 26, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
